🇺🇸 FDA
Patent

US 9605255

Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell

granted A61KA61K31/7088A61K31/712

Quick answer

US patent 9605255 (Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell) held by ProQR Therapeutics II B.V. expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ProQR Therapeutics II B.V.
Grant date
Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/7088, A61K31/712, A61K38/465, A61K45/06